Avantor’s (AVTR) “Neutral” Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. reiterated their neutral rating on shares of Avantor (NYSE:AVTR) in a report released on Thursday morning, MarketBeat Ratings reports. They currently have a $12.00 price objective on the stock, down from their prior price objective of $14.00.

AVTR has been the subject of several other reports. Jefferies Financial Group reissued a “hold” rating on shares of Avantor in a research note on Friday, August 1st. Stifel Nicolaus set a $12.00 target price on Avantor and gave the stock a “hold” rating in a research note on Monday, August 4th. UBS Group set a $12.00 target price on Avantor in a research note on Thursday. Morgan Stanley lowered their target price on Avantor from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Monday, August 4th. Finally, Robert W. Baird boosted their target price on Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Five research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $14.42.

Avantor Trading Up 6.9%

Shares of NYSE AVTR opened at $11.82 on Thursday. Avantor has a twelve month low of $10.82 and a twelve month high of $23.70. The company has a current ratio of 1.49, a quick ratio of 0.67 and a debt-to-equity ratio of 0.65. The stock has a fifty day simple moving average of $13.33 and a 200-day simple moving average of $13.26. The stock has a market capitalization of $8.06 billion, a PE ratio of -90.89, a PEG ratio of 4.08 and a beta of 0.98.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The firm had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period in the previous year, the firm posted $0.26 earnings per share. The company’s quarterly revenue was down 5.3% compared to the same quarter last year. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. On average, equities analysts forecast that Avantor will post 1.06 earnings per share for the current year.

Insider Activity

In other Avantor news, Director Gregory L. Summe acquired 100,000 shares of the stock in a transaction dated Thursday, October 30th. The stock was acquired at an average cost of $11.25 per share, with a total value of $1,125,000.00. Following the transaction, the director owned 300,000 shares in the company, valued at $3,375,000. The trade was a 50.00% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Steven W. Eck sold 3,476 shares of the company’s stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total value of $39,591.64. Following the transaction, the chief accounting officer directly owned 55,068 shares of the company’s stock, valued at approximately $627,224.52. This represents a 5.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.20% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. TD Private Client Wealth LLC boosted its position in shares of Avantor by 9.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock worth $100,000 after acquiring an additional 670 shares in the last quarter. Signaturefd LLC boosted its position in shares of Avantor by 19.8% during the 1st quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock worth $89,000 after acquiring an additional 904 shares in the last quarter. Truist Financial Corp lifted its holdings in shares of Avantor by 2.2% in the 2nd quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock valued at $597,000 after purchasing an additional 959 shares during the last quarter. Xponance Inc. lifted its holdings in shares of Avantor by 0.9% in the 1st quarter. Xponance Inc. now owns 114,422 shares of the company’s stock valued at $1,855,000 after purchasing an additional 966 shares during the last quarter. Finally, SG Americas Securities LLC lifted its holdings in shares of Avantor by 2.7% in the 2nd quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock valued at $499,000 after purchasing an additional 979 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.